SCHEMBL806188

SCHEMBL806188

CCc1ccc2c(ccn2C(C)=O)c1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.54
CYP11B1 P15538 5/20 0.49
CYP11B2 P19099 5/20 0.49
OXER1 Q8TDS5 2/20 0.47
S1PR1 P21453 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
DRD3 P35462 1/20 0.40
KCNH2 Q12809 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2A6 P11509 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9001732 0.87 NOTUM (0.54) NOTUMCYP11B1CYP11B2OXER1KDM4E
SCHEMBL10716531 0.84 NOTUM (0.51) NOTUMCYP11B1CYP11B2OXER1S1PR1
SCHEMBL12043978 0.79 PIK3CD (0.44) OXER1S1PR1AKR1C3AKR1C2
SCHEMBL10837082 0.77 NOTUM (0.59) NOTUMCYP11B1CYP11B2KDM4EALDH1A1
SCHEMBL853076 0.76 NOTUM (0.58) NOTUMCYP11B1CYP11B2OXER1KDM4E
SCHEMBL31607288 0.76 NOTUM (0.58) NOTUMCYP11B1CYP11B2KDM4EALDH1A1
SCHEMBL795182 0.76 NOTUM (0.58) NOTUMCYP11B1CYP11B2OXER1KDM4E
SCHEMBL12749675 0.76 NOTUM (0.58) NOTUMCYP11B1CYP11B2KDM4EALDH1A1
SCHEMBL29445622 0.75 TFPI2 (0.42) CYP11B1CYP11B2OXER1S1PR1HSD17B10
SCHEMBL5066779 0.75 NOTUM (0.56) NOTUMCYP11B1CYP11B2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012037411-A9 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF ARAGON PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed
WO-2012037411-A2 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF ARAGON PHARMACEUTICALS, INC. (US) 2012-03-22 WO disclosed